VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...
Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market ...
Mordor Intelligence has published a new report on cellulite treatment market offering a comprehensive analysis of trends, growth drivers, and future projections.
Lululemon’s management is under pressure. It is reasonable to expect they will use January to tidy up their affairs and reset ...
Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.
Zacks.com on MSN
3 Medical Instrument Stocks to Counter Industry Woes Using GenAI
VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback